Literature DB >> 6980745

Immunological responses of healthy elderly population.

J S Goodwin, R P Searles, K S Tung.   

Abstract

We measured in vitro mitogen responses, delayed hypersensitivity skin tests, circulating immune complexes (CIC) and three autoantibodies in 279 healthy and 24 chronically ill individuals over 65, and in young controls. The elderly individuals had previously undergone a complete medical examination and laboratory screening tests, and were on no medications. Compared to the results of 180 young controls tested concurrently, the healthy elderly individuals had significantly depressed PHA responses and skin test responses. In addition, CIC and autoantibodies were increased in the healthy elderly group compared to young controls. There was no difference in PHA or skin test responses between the healthy and chronically ill elderly subjects, suggesting that the major determinant of depressed cellular immunity in the elderly is age per se and not age-associated diseases. Within the elderly population, aged 65-94, there was a significant decrease in PHA response with age. Previously it has been reported that correlations exist between measurements of cellular immune response (mitogen response and skin testing) and manifestations of autoimmunity (CIC or autoantibodies) in elderly subjects. However, in this well characterized healthy elderly population we could not verify an association between the cellular immune response and either autoantibodies or immune complexes. In addition, was no increased prevalence of autoantibodies in subjects with CIC.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980745      PMCID: PMC1536458     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Ageing and immunological function in man.

Authors:  I R Mackay
Journal:  Gerontologia       Date:  1972

2.  The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus.

Authors:  N F Rothfield; B D Stollar
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

3.  Ageing, immune response, and mortality.

Authors:  I C Roberts-Thomson; S Whittingham; U Youngchaiyud; I R Mackay
Journal:  Lancet       Date:  1974-08-17       Impact factor: 79.321

4.  Lymphocyte phytohemagglutinin responsiveness, immunoglobulins and autoantibodies in aging humans.

Authors:  H M Hallgren; C E Buckley; V A Gilbertsen; E J Yunis
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

5.  Occupation and physical activity and coronary heart disease.

Authors:  J Cassel; S Heyden; A G Bartel; B H Kaplan; H A Tyroler; J C Cornoni; C G Hames
Journal:  Arch Intern Med       Date:  1971-12

6.  Cytotoxins in disease. Autocytotoxins in lupus.

Authors:  P I Terasaki; V D Mottironi; E V Barnett
Journal:  N Engl J Med       Date:  1970-10-01       Impact factor: 91.245

7.  Serum anti-gamma-globulin and antinuclear factors in the aged.

Authors:  R J Cammarata; G P Rodnan; R H Fennell
Journal:  JAMA       Date:  1967-02-13       Impact factor: 56.272

8.  Cell-mediated immunity in an ageing population.

Authors:  J P Girard; M Paychère; M Cuevas; B Fernandes
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

9.  Autoimmunity and aging: the age-related response of mice of a long-lived strain to trinitrophenylated syngeneic mouse red blood cells.

Authors:  D Naor; B Bonavida; R L Walford
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

10.  Immunological studies of aging. II. Loss of IgG and high avidity plaque-forming cells and increased suppressor cell activity in aging mice.

Authors:  E A Goidl; J B Innes; M E Weksler
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  23 in total

1.  Finding Balance: T cell Regulatory Receptor Expression during Aging.

Authors:  Mary M Cavanagh; Qian Qi; Cornelia M Weyand; Jörg J Goronzy
Journal:  Aging Dis       Date:  2011-10-28       Impact factor: 6.745

Review 2.  Immunosenescence revisited. Does it have any clinical significance?

Authors:  A J Voets; L R Tulner; G J Ligthart
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

3.  The prevalence of autoantibodies in an elderly sub-Saharan African population.

Authors:  R Njemini; I Meyers; C Demanet; J Smitz; M Sosso; T Mets
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

4.  Natural autoantibodies in the serum of healthy women--a five-year follow-up.

Authors:  O Yadin; B Sarov; L Naggan; H Slor; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

5.  Defective opsonization of Haemophilus influenzae by sera of elderly patients.

Authors:  N D Garbett; G S Matharu; P J Cole
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

6.  Diagnostic importance of an elevated erythrocyte sedimentation rate in the elderly.

Authors:  P D Thomas; J S Goodwin
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

7.  Effects of three plant growth regulators on the immune response of young and aged deer mice Peromyscus maniculatus.

Authors:  A Fairbrother; T M Yuill; L J Olson
Journal:  Arch Environ Contam Toxicol       Date:  1986-05       Impact factor: 2.804

8.  Autoantibodies to purified nuclear proteins related to DNA metabolism during ageing and in SLE patients.

Authors:  G C Astaldi Ricotti; M Pazzaglia; A M Martelli; A Cerino; M Bestagno; A Caprelli; S Riva; M A Pedrini; A Facchini
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

9.  Alcohol intake in a healthy elderly population.

Authors:  J S Goodwin; C J Sanchez; P Thomas; C Hunt; P J Garry; J M Goodwin
Journal:  Am J Public Health       Date:  1987-02       Impact factor: 9.308

Review 10.  Low zinc status: a new risk factor for pneumonia in the elderly?

Authors:  Junaidah B Barnett; Davidson H Hamer; Simin N Meydani
Journal:  Nutr Rev       Date:  2010-01       Impact factor: 7.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.